| scholarly article | Q13442814 |
| P50 | author | Zhengxiang He | Q56389260 |
| Lili Chen | Q56796365 | ||
| Anitha Jayaprakash | Q57320103 | ||
| Jose C Clemente | Q87191879 | ||
| Sebastiao N Martins-Filho | Q88301922 | ||
| Glaucia C Furtado | Q90495838 | ||
| P2093 | author name string | Jeremiah J Faith | |
| Sergio A Lira | |||
| Juan J Lafaille | |||
| Jean-Frederic Colombel | |||
| Ravi Sachidanandam | |||
| Alina Cornelia Iuga | |||
| Madhura Deshpande | |||
| P2860 | cites work | Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 | Q24290619 |
| A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R | Q24297906 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| Interleukin-23 drives innate and T cell-mediated intestinal inflammation | Q24677051 | ||
| Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives | Q28085134 | ||
| Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death | Q28199430 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases | Q30249313 | ||
| Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. | Q33662701 | ||
| Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. | Q33745764 | ||
| Role of the gut microbiota in immunity and inflammatory disease | Q34036490 | ||
| IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 | Q34521302 | ||
| Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. | Q34543673 | ||
| IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. | Q34572769 | ||
| Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice | Q35109824 | ||
| The gut microbiota in mouse models of inflammatory bowel disease | Q35117031 | ||
| Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
| A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility | Q36198073 | ||
| Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses | Q37200518 | ||
| Host and microbiota interactions are critical for development of murine Crohn's-like ileitis. | Q37265536 | ||
| IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism | Q37325464 | ||
| IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. | Q37497970 | ||
| An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease | Q37729775 | ||
| Diet and microbiota in inflammatory bowel disease: The gut in disharmony | Q37730870 | ||
| Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense | Q38080684 | ||
| Epidemiology and risk factors for IBD. | Q38366954 | ||
| Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. | Q38444161 | ||
| Inflammatory disease caused by intestinal pathobionts | Q39131979 | ||
| Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn's Disease | Q40351437 | ||
| Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice | Q41019883 | ||
| Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
| IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. | Q41964089 | ||
| Interleukin-23 drives intestinal inflammation through direct activity on T cells | Q42083897 | ||
| Ustekinumab induction and maintenance therapy in refractory Crohn's disease | Q42514321 | ||
| Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation | Q44458138 | ||
| Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). | Q44791207 | ||
| IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells | Q46043893 | ||
| Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis | Q46339795 | ||
| Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. | Q46413941 | ||
| Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study | Q46482643 | ||
| Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study | Q46587088 | ||
| Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice. | Q47365730 | ||
| Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 | ||
| Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]. | Q47923338 | ||
| Systemic activation and antigen-driven oligoclonal expansion of T cells in a mouse model of colitis. | Q52170642 | ||
| Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing. | Q53109633 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 1177-1191.e16 | |
| P577 | publication date | 2018-06-15 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Diet Modifies Colonic Microbiota and CD4+ T-Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-Cell Expression of Interleukin 23 | |
| P478 | volume | 155 |
| Q64994358 | Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients. |
| Q90495846 | Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23 |
| Q91615855 | Macrophage interactions with fungi and bacteria in inflammatory bowel disease |
| Q95300919 | Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice |
Search more.